701 related articles for article (PubMed ID: 23832679)
41. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
[TBL] [Abstract][Full Text] [Related]
42. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
[TBL] [Abstract][Full Text] [Related]
43. Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro.
Wang W; Long L; Wang L; Tan C; Fei X; Chen L; Huang Q; Liang Z
Cancer Lett; 2016 Feb; 371(2):274-84. PubMed ID: 26706414
[TBL] [Abstract][Full Text] [Related]
44. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
45. CD133 is a marker of bioenergetic stress in human glioma.
Griguer CE; Oliva CR; Gobin E; Marcorelles P; Benos DJ; Lancaster JR; Gillespie GY
PLoS One; 2008; 3(11):e3655. PubMed ID: 18985161
[TBL] [Abstract][Full Text] [Related]
46. Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells.
Fang KM; Yang CS; Lin TC; Chan TC; Tzeng SF
Neuro Oncol; 2014 Apr; 16(4):552-66. PubMed ID: 24327583
[TBL] [Abstract][Full Text] [Related]
47. PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.
Cheng RB; Ma RJ; Wang ZK; Yang SJ; Lin XZ; Rong H; Ma Y
Mol Cell Biochem; 2011 Mar; 349(1-2):149-57. PubMed ID: 21110069
[TBL] [Abstract][Full Text] [Related]
48. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.
Gwak HS; Park MJ; Park IC; Woo SH; Jin HO; Rhee CH; Jung HW
J Neurosurg; 2014 Dec; 121(6):1483-91. PubMed ID: 25303017
[TBL] [Abstract][Full Text] [Related]
49. Expression of multidrug resistance genes in normal and cancer stem cells.
Shervington A; Lu C
Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of Hes-1, a downstream target of notch signaling in hepatocellular carcinoma.
Zou JH; Xue TC; Sun C; Li Y; Liu BB; Sun RX; Chen J; Ren ZG; Ye SL
Asian Pac J Cancer Prev; 2015; 16(9):3811-6. PubMed ID: 25987042
[TBL] [Abstract][Full Text] [Related]
51. [Effect of RNA interference inhibition to expression of CD133 on tumor cell biological characteristics in KATO-III CD133(+) cells of human gastric cancer].
Wang SL; Yu JW; Cai C; Lu RQ; Wu JG; Ni XC; Jiang BJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):889-94. PubMed ID: 24062002
[TBL] [Abstract][Full Text] [Related]
52. c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells.
Yoon CH; Kim MJ; Kim RK; Lim EJ; Choi KS; An S; Hwang SG; Kang SG; Suh Y; Park MJ; Lee SJ
Oncogene; 2012 Nov; 31(44):4655-66. PubMed ID: 22249269
[TBL] [Abstract][Full Text] [Related]
53. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
Di K; Linskey ME; Bota DA
Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
[TBL] [Abstract][Full Text] [Related]
54. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
[TBL] [Abstract][Full Text] [Related]
55. Notch promotes radioresistance of glioma stem cells.
Wang J; Wakeman TP; Lathia JD; Hjelmeland AB; Wang XF; White RR; Rich JN; Sullenger BA
Stem Cells; 2010 Jan; 28(1):17-28. PubMed ID: 19921751
[TBL] [Abstract][Full Text] [Related]
56. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V
Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487
[TBL] [Abstract][Full Text] [Related]
57. CXCR4-positive subset of glioma is enriched for cancer stem cells.
Zheng X; Xie Q; Li S; Zhang W
Oncol Res; 2011; 19(12):555-61. PubMed ID: 22812188
[TBL] [Abstract][Full Text] [Related]
58. Interference of Notch1 inhibits the growth of glioma cancer cells by inducing cell autophagy and down-regulation of Notch1-Hes-1 signaling pathway.
Yao J; Zheng K; Li C; Liu H; Shan X
Med Oncol; 2015 Jun; 32(6):610. PubMed ID: 25920606
[TBL] [Abstract][Full Text] [Related]
59. Expression of NANOG in human gliomas and its relationship with undifferentiated glioma cells.
Niu CS; Li DX; Liu YH; Fu XM; Tang SF; Li J
Oncol Rep; 2011 Sep; 26(3):593-601. PubMed ID: 21573506
[TBL] [Abstract][Full Text] [Related]
60. Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation.
Zhang X; Chen T; Zhang J; Mao Q; Li S; Xiong W; Qiu Y; Xie Q; Ge J
Cancer Sci; 2012 Feb; 103(2):181-90. PubMed ID: 22093097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]